This application relates to compounds of Formula (I):(I),or pharmaceutically acceptable salts or stereoisomers thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.本申請案係關於式(I)化合物：(I)，或其醫藥學上可接受之鹽或立體異構物，其調節腺苷受體諸如亞型A2A及A2B受體之活性且適用於治療與腺苷受體之活性相關之疾病，包括例如癌症、發炎性疾病、心血管疾病及神經退化性疾病。
